Do guidelines change outcomes in ventilator-associated pneumonia?

Current Opinion in Infectious Diseases

Volumn 23, Issue 2, 2010, Pages 171-177

  Bassi, Gianluigi Li ^a   Ferrer, Miguel ^a   Saucedo, Lina M ^a   Torres, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Critical care; Guidelines; Mortality; Ventilator associated pneumonia

Indexed keywords

ACINETOBACTER; ANTIBIOTIC THERAPY; ASPERGILLUS FUMIGATUS; CANDIDA; CLINICAL EDUCATION; CLINICAL PROTOCOL; HUMAN; KLEBSIELLA PNEUMONIAE; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; STENOTROPHOMONAS MALTOPHILIA; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GUIDELINES AS TOPIC; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

EID: 77649241363     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328337241a     Document Type: Review

References (35)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644.
3. Bergmans DC, Bonten MJ, Gaillard CA, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001; 164:382-388.
4. Dezfulian C, Shojania K, Collard HR, et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005; 118:11-18.
5. Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354:1851-1858.
6. Lorente L, Lecuona M, Jimenez A, et al. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 2007; 176:1079-1083.
7. Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 2009; 37:2709-2718.
8. Kollef MH, Silver P, Murphy DM,Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662.
9. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-394.
10. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268.
11. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-asso ciated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
12. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus state ment, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153:1711-1725.
13. Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35:9-29.
14. Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 1992; 20:740-745.
15. Delisle MS, Williamson DR, Perreault MM, et al. The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 2008; 23:11-17.
16. Meersseman W, Lagrou K, Spriet I, et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35:1526-1531.
17. Daubin C, Vincent S, Vabret A, et al. Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. Intensive Care Med 2005; 31:1116-1122.
18. Heininger A, Jahn G, Engel C, et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001; 29:541-547.
19. Jaber S, Jung B, Corne P, et al. An intervention to decrease complications related to endotracheal intubation in the intensive care unit: a prospective, multiple-center study. Intensive Care Med 2009 [Epub ahead of print].
20. Papazian L, Fraisse A, Garbe L, et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84:280-287.
21. Chiche L, Forel JM, Roch A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009; 37:1850-1857.
22. Nachtigall I, Tamarkin A, Tafelski S, et al. Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med 2009; 37:159-166.
23. Sinuff T, Muscedere J, Cook D, et al. Ventilator-associated pneumonia: improving outcomes through guideline implementation. J Crit Care 2008; 23:118-125.
24. SooHooGW, Wen YE, Nguyen TV, Goetz MB. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005; 128:2778-2787.
25. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115.
26. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539.
27. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across fourtreatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613.
28. Leroy O, Giradie P, Yazdanpanah Y, et al. Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens. Eur Respir J 2002; 20:432-439.
29. Ioanas M, Cavalcanti M, Ferrer M, et al. Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J 2003; 22:876-882.
30. Ferrer M, Liapikou A, Valencia M, et al. Validation of the ATS/IDSA guidelines for hospital-acquired pneumonia in the intensive care unit. Clin Infect Dis (in press).
31. Langer M, Cigada M, Mandelli M, et al. Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med 1987; 13:342-346.
32. GastmeierP,SohrD,GeffersC,etal. Early-and late-onset pneumonia: isthis still a useful classification? Antimicrob Agents Chemother 2009; 53:2714-2718.
33. Giantsou E, Liratzopoulos N, Efraimidou E, et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multi-resistant bacteria. Intensive Care Med 2005; 31:1488-1494.
34. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371:126-134.
35. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477.